Haleon (LSE:HLN) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon ROE % Adjusted to Book Value?

Haleon's ROE % for the quarter that ended in Mar. 2024 was 10.19%. Haleon's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Haleon's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

Haleon ROE % Adjusted to Book Value Historical Data

The historical data trend for Haleon's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon ROE % Adjusted to Book Value Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

2.69

3.56

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-	4.01	-	-0.04	-

Competitive Comparison of Haleon's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Haleon's ROE % Adjusted to Book Value falls into.

Haleon ROE % Adjusted to Book Value Calculation

Haleon's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	6.37%	/	1.79
	=	3.56%

Haleon's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.19%	/	N/A
	=	N/A

Haleon ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Haleon's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (LSE:HLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (LSE:HLN) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.